The day-long seminar will be chaired by Dr K Krishna Murthy, department of virology, Southwest Foundation for Biomedical Research, Texas, US. It will comprise of two technical sessions that will focus on different kinds of vaccines including the most sought after ones like HIV, cholera, and meningitis vaccines.
The focus of the conference is on India becoming a leader in vaccines and facing challenges in the post-2005 situation. While some of the multinational pharma companies are focussing on big-dollar blockbuster drugs, developing countries are still struggling to protect their huge population from common, life-threatning diseases due to lack of availability of vaccines at affordable prices, Dr BS Bajaj, AIBA-SC, chairman told FE.
With Hyderabad also called the `vaccine hub' of India housing major players like Shantha Biotechnics, Bharat Biotech, Indian Immunologicals, Biological E, etc, India has taken a lead in the manufacture and distribution of low-cost vaccines to the developing countries. Currently, vaccines for rabies, anthrax, cholera, dengue, malaria, TB, and Hepatitis C are under advanced stages of development in India, Dr Bajaj added.
The conference also proposes to have a panel discussion touching various regulatory and ethical issues and analyse the role of the state, Central governments and FIs to help in the growth of the vaccine industry.